Bioorganic & Medicinal Chemistry Letters 1998-01-20

Synthesis, DNA-damaging and cytotoxic properties of novel topoisomerase II-directed bisantrene analogues.

G Zagotto, A Oliva, F Guano, E Menta, G Capranico, M Palumbo

Index: Bioorg. Med. Chem. Lett. 8(2) , 121-6, (1998)

Full Text: HTML

Abstract

New bisantrene analogues were synthesized, bearing one or two 4,5-dihydro-1H-imidazol-2-yl hydrazone side chains at positions 1,4 or 9 of the anthracene ring system. A 10-azabioisostere was also prepared. The position of substituents in structurally isomeric drugs modulates topoisomerase II poisoning and specificity, along with cytotoxicity.

Related Compounds

  • Bisantrene

Related Articles:

In vitro effects of bisantrene on fresh clonogenic leukemia cells: a preliminary study on 15 cases.

1990-01-01

[Haematologica 75(6) , 527-31, (1990)]

Phase II trial of Bisantrene for metastatic melanoma: an Illinois cancer council study.

1991-01-01

[Med. Pediatr. Oncol. 19(2) , 126-8, (1991)]

Retroviral transfer of the human MDR1 gene confers resistance to bisantrene-specific hematotoxicity.

2014-04-29

[Clin. Cancer Res. 2(6) , 973-80, (1996)]

Bisantrene in advanced, hormone-resistant carcinoma of the prostate: an Illinois Cancer Council phase II study.

1990-08-01

[Invest. New Drugs 8(3) , 313-5, (1990)]

Bisantrene in relapsed and refractory acute myelogenous leukemia.

1993-02-01

[Leuk. Lymphoma 9(3) , 217-20, (1993)]

More Articles...